| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −2.0× | −1.7× | |
| Price / Book | 1.6× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −2.4× | −1.5× | |
| EV / EBITDA | −0.8× | −1.2× | |
| Earnings yield | −49.1% | −14.3% | |
| Free cash flow yield | −41.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,297.84 | +4.64% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.45 | +2.23% | $625.25B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.18 | +2.30% | $511.01B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.90 | +3.69% | $378.7B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.46 | +3.36% | $366.28B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.29 | +2.06% | $282.59B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.41 | +2.72% | $261.19B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $685.86 | +0.95% | $253.59B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.18 | +2.17% | $234.73B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.67 | +1.70% | $193.02B | 22.3× | 37.5% | +29.9% |
